Literature DB >> 10656272

Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants.

M Sahin1, I Bernay, T Basoglu, F Canturk.   

Abstract

Tc-99m polyclonal immunoglobulin-G has been shown to be a successful agent in the depiction of active inflammation in rheumatoid arthritis (RA). The objective of this study was to compare the uptake behaviors of Tc-99m HIG and Tc-99m MDP in RA and variants of rheumatoid arthritis (VRA). Seventeen patients with RA and 8 patients with VRA presenting with active inflammation were included in this study. Ten subjects with well-diagnosed degenerative joint disease constituted the control group. All joints in patients were also imaged with Tc-99m HSA to evaluate the vascularization status of the joints. Tc-99m HIG and HSA scans were obtained at 2, 4 and 24 hours after the injection of 555 MBq Tc-99m HIG and 296 MBq Tc-99m HSA. Conventional bone scans were performed 4 hours after the injection of 740 MBq Tc-99m MDP. Target-to-background (T/B) ratios were obtained exclusively over the joint regions. Tc-99m HIG T/B ratios of the active joints in RA were significantly higher than those of the non-active joints and the control group (p < 0.05). Tc-99m HIG T/B ratios in active joints showed a progressive increase between 2 and 24 hour images (p < 0.05). In contrast, Tc-99m HSA T/B ratios decreased in all active joints significantly (p < 0.05) except the ankle joint region (p > 0.05). The T/B ratios in Tc-99m MDP bone scans were higher in all active joints than in non-active RA joints and joints of controls but significantly differences were only detected in wrist and elbow joints. All clinically active joints in VRA patients accumulated Tc-99m HIG and HSA, and showed increased Tc-99m MDP uptake. These joints had a very similar Tc-99m HIG retention pattern to the RA joints. The detection rate of active joint inflammation with Tc-99m HIG was much higher than that with Tc-99m MDP. The increasing Tc-99m HIG uptake ratio between 2 and 24 hours in contrast to Tc-99m HSA indicates the presence of other binding mechanisms besides increased vascularity in RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10656272     DOI: 10.1007/bf03164932

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  7 in total

1.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 2.  Rheumatoid arthritis: Nuclear Medicine state-of-the-art imaging.

Authors:  Paulo Henrique Rosado-de-Castro; Sergio Augusto Lopes de Souza; Dângelo Alexandre; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  World J Orthop       Date:  2014-07-18

3.  Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.

Authors:  G Gerasimou; E Moralidis; E Papanastasiou; G Liaros; T Aggelopoulou; E Triantafyllidou; N Lytras; L Settas; A Gotzamani-Psarrakou
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

4.  Evaluation of a candidate anti-arthritic drug using the mouse collagen antibody induced arthritis model and clinically relevant biomarkers.

Authors:  Andrew T Bender; Mark Spyvee; Takashi Satoh; Benjamin Gershman; Tyler Teceno; Laurette Burgess; Vipul Kumar; Yin Wu; Hua Yang; Yueyun Ding; Sandeep Akare; Qian Chen
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

Review 5.  Bone scintigraphy in patients with pain.

Authors:  Seung Hyeon Shin; Seong Jang Kim
Journal:  Korean J Pain       Date:  2017-06-30

6.  The Agreement Between Blood Pool - Delayed Bone Scintigraphy and Tc-99m Human Immunoglobulin G (HIG) Scintigraphy in the Determination of the Presence and Severity of Inflammatory Arthritis.

Authors:  Gulizar Kacar; Cahit Kacar; Firat Gungor
Journal:  Mol Imaging Radionucl Ther       Date:  2011-08-01

Review 7.  Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques.

Authors:  Stéphanie Put; René Westhovens; Tony Lahoutte; Patrick Matthys
Journal:  Arthritis Res Ther       Date:  2014-04-15       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.